Substituted 1,4-benzodiazepines and uses thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 27, 2006
Grant Date -
Jun 12, 2003
app pub date -
Nov 13, 2002
filing date -
Nov 13, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention is directed to novel 1,4-benzodiazepines, pharmaceutical compositions thereof, and the use thereof as inhibitors of HDM2-p53 interactions. Compounds have Formula I: ##STR00001## or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein: X and Y are independently --C(O)--, --CH.sub.2-- or --C(S)--; R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.7, R.sup.8, R.sup.b, R.sup.c, R.sup.d and M are defined herein; R.sup.5 is hydrogen, alkyl, cycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted aralkyl, optionally substituted heteroaralkyl, carboxyalkyl, alkoxycarbonyl, alkoxycarbonylalkyl, aminocarbonyl, aminocarbonylalkyl, alkylaminocarbonyl or alkylaminocarbonylalkyl; R.sup.6 is cycloalkyl, aryl, heteroaryl, cycloalkylalkyl, aralkyl, heteroarylalkyl, or a saturated or partially unsaturated heterocycle, each of which is optionally substituted; R.sup.9 is cycloalkyl, aryl, heteroaryl, a saturated or partially unsaturated heterocycle, cycloalkyl(alkyl), aralkyl or heteroarylalkyl, each of which is optionally substituted; and R.sup.10 is --(CH.sub.2).sub.n--CO.sub.2R.sup.b, --(CH.sub.2).sub.m--CO.sub.2M, --(CH.sub.2).sub.i--OH or --(CH.sub.2).sub.j--CONR.sup.cR.sup.d n is 0 8, m is 0 8, i is 1 8 and j is 0 8.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully